A total of 1246 clinical isolates of
Haemophilus influenzae from pediatric patients were recovered in Chiba Municipal Hospital. We studied the characteristics of these strains with
regard to β-lactamase production and in vitro activities of antimicrobial agents between January 1995 and June 1997. Two hundred
and ten strains (16.8%) of these isolates produced β-lactamase. Eight β-lactamase-positive isolates were resistant to amoxicillin-clavulanate
(MICs, ≥12 μg/mL). Most of these were isolated from respiratory tracts. These strains were mainly cultured from boys less
than 3 years old with chronic respiratory disease. Two strains were serotype b and 6 strains were not typeable. Some of these
strains were eradicated without antibiotic treatment. Although the clinical impact of β-lactamase-producing and amoxicillin-clavulanate-resistant
Haemophilus influenzae remains low, the number of infections caused by these strains may increase in the near future. We must monitor this tendency.
Key words β-lactamase - resistance - amoxicillin-clavulanate -
Haemophilus influenzae